• Pol II Degradation Triggers Cell Death Beyond Transcription

  2026-05-22

  This study uncovers that targeted degradation of RNA polymerase II (Pol II) initiates cell death through mechanisms independent of gene transcription shutdown. The findings reveal a novel layer of the DNA damage response, reshaping how researchers interpret Pol II's role in cellular fate and cancer biology.

• In Vitro Macrolide Pharmacodynamics Against M. mycoides SC

  2026-05-22

  This study investigates the in vitro pharmacodynamics of gamithromycin and other macrolide antibiotics against Mycoplasma mycoides subspecies mycoides Small Colony (MmmSC), the agent of contagious bovine pleuropneumonia. By comparing activity in artificial medium and bovine serum, the work reveals striking matrix-dependent differences and highlights methodological considerations for optimizing antibacterial research.

• Unlocking LAG-3 Pathways: FDA-Approved Libraries in Immunoth

  2026-05-21

  This thought-leadership article examines how the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) catalyzes translational breakthroughs in targeting immune checkpoints such as LAG-3. Integrating mechanistic insights from recent research and practical workflow guidance, it provides strategic recommendations for researchers seeking to harness FDA-approved bioactive compound libraries for drug repositioning, pharmacological target identification, and high-throughput screening in cancer immunotherapy and neurodegenerative disease discovery.

• SAG: Smoothened Receptor Agonist for Advanced Assays

  2026-05-21

  Smoothened Agonist (SAG) enables precise Hedgehog pathway activation, powering both neurodegeneration and stem cell maintenance research. This article details cutting-edge workflows, troubleshooting, and comparative insights for maximizing reproducibility and translational impact with SAG.

• Ertapenem Sodium Salt: Pharmacokinetics, Resistance, and Ass

  2026-05-20

  Explore the pharmacokinetics and resistance implications of Ertapenem sodium salt in advanced antibacterial research. This article delivers actionable insights into assay design, referencing the latest transmission dynamics data for informed decision-making.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-05-20

  The Hoechst 33342/PI Double Staining Kit provides a practical method for differentiating apoptotic, necrotic, and viable cells using dual fluorescent labeling. It is best suited for basic research workflows requiring direct visualization of cell death states and is not intended for diagnostic or clinical use.

• EdU Flow Cytometry Assay Kits (Cy5): Advancing S-Phase DNA D

  2026-05-19

  Unlock unrivaled sensitivity and workflow flexibility in cell proliferation research with EdU Flow Cytometry Assay Kits (Cy5). This article demystifies click chemistry DNA synthesis detection, detailing real-world applications, troubleshooting strategies, and actionable parameters for robust cell cycle analysis.

• Comparing SGLT2 Inhibitors in Type 2 Diabetes and Heart Fail

  2026-05-19

  This systematic review and network meta-analysis rigorously compared the cardiovascular outcomes of individual SGLT2 inhibitors, including Ertugliflozin (PF-04971729), in patients with type 2 diabetes and heart failure. The study clarifies the relative efficacy of these agents on heart failure hospitalization and composite cardiovascular events, informing both clinical and research priorities.

• PDI Inhibition Enhances Panobinostat Efficacy in Myeloma Mod

  2026-05-18

  This study demonstrates that the PDI inhibitor LTI6426 synergistically increases the anti-myeloma activity of panobinostat at reduced, less toxic doses. The findings highlight a promising strategy for optimizing epigenetic therapy in multiple myeloma by targeting ER stress pathways and identifying pharmacodynamic biomarkers.

• S-Adenosylmethionine (SAM): Precision in Neuroepigenetic Res

  2026-05-18

  Explore the advanced scientific applications of S-adenosylmethionine (Ademetionine) as a methyl donor in neuroepigenetic and translational research. This article delivers new insights into quantitative assay design, clinical relevance, and workflow optimization—distinct from existing coverage.

• PD 173074: Precision FGFR/VEGFR2 Inhibition for Cancer Resea

  2026-05-17

  PD 173074 stands out as a robust, highly selective FGFR1 and VEGFR2 inhibitor, streamlining experimental workflows in oncology and angiogenesis research. This article details applied protocols, troubleshooting strategies, and translational insights for maximizing reproducibility and data confidence with this APExBIO reagent.

• DMH-1 as a Precision ALK2 Inhibitor: Deepening BMP Pathway C

  2026-05-16

  Explore the advanced use of DMH1 as a selective ALK2 inhibitor in organoid and lung cancer research. This article unveils practical, evidence-driven insights for assay optimization and differentiation strategies, offering a novel perspective on BMP pathway modulation.

• Acifran: Optimizing Lipid Metabolism Research Workflows

  2026-05-15

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) delivers unrivaled selectivity for HM74A/GPR109A and GPR109B, facilitating reproducible lipid metabolism research. This guide details stepwise protocols, troubleshooting strategies, and the structural innovations that set Acifran apart for metabolic disorder studies.

• TRPV1+ Nerve Stimulation Suppresses Inflammation via Reflex

  2026-05-15

  Song et al. (2025) reveal that targeted stimulation of TRPV1+ peripheral somatosensory nerves initiates a somato-autonomic reflex that rapidly suppresses systemic inflammation. This mechanistic insight clarifies neuro-immune circuitry and informs translational strategies for modulating inflammatory responses.

• Methylprednisolone Sodium Succinate in Inflammation Research

  2026-05-14

  Methylprednisolone Sodium Succinate (SKU B4953) from APExBIO unlocks reproducible immunomodulation for inflammation studies, tumor cell apoptosis assays, and acute injury models. This guide translates up-to-date evidence and practical troubleshooting into clear, actionable protocols for synthetic corticosteroid integration.

15834 records 1/1056 page Next 12345 下5页 Last page